Wang Yongzhi, Luo Lingtao, Mörgelin Matthias, Thorlacius Henrik
Department of Clinical Sciences, Malmö, Section for Surgery, Lund University, Sweden.
Department of Clinical Sciences, Malmö, Section for Surgery, Lund University, Sweden; Department of Surgery, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Biochem Biophys Res Commun. 2017 Jun 10;487(4):887-891. doi: 10.1016/j.bbrc.2017.04.147. Epub 2017 Apr 29.
Dysfunctional coagulation aggravates clinical outcome in patients with sepsis. The aim of this study was to define the role of Rac-1 in the formation of platelet-derived microparticles (PMPs) and thrombin generation (TG) in abdominal sepsis. Male C57BL/6 mice underwent cecal ligation and puncture (CLP). Scanning electron microscopy and flow cytometry were used to quantify PMPs. TG was determined by use of a fluorimetric assay. It was found that CLP increased Rac1 activity in platelets, which was abolished by administration of the Rac1 inhibitor NSC23766. Sepsis-induced TG in vivo was reflected by reduced capacity of plasma from septic animals to generate thrombin ex vivo. Administration of NSC23766 increased peak and total TG in plasma from CLP mice indicating that Rac-1 regulates sepsis-induced formation of thrombin. The number of circulating PMPs was markedly elevated in animals with abdominal sepsis. Treatment with NSC23766 significantly decreased formation of PMPs in septic mice. Platelet activation in vitro caused release of numerous MPs. Notably, NSC23766 abolished PMP formation in activated platelets in vitro. These findings suggest that Rac-1 regulates PMP formation and TG in sepsis and that inhibition of Rac1 activity could be a useful target to inhibit dysfunctional coagulation in abdominal sepsis.
凝血功能障碍会加重脓毒症患者的临床结局。本研究的目的是确定Rac-1在腹部脓毒症中血小板衍生微粒(PMPs)形成和凝血酶生成(TG)中的作用。雄性C57BL/6小鼠接受盲肠结扎和穿刺(CLP)。采用扫描电子显微镜和流式细胞术对PMPs进行定量。通过荧光测定法测定TG。研究发现,CLP可增加血小板中的Rac1活性,而Rac1抑制剂NSC23766可消除这种活性。脓毒症诱导的体内TG可通过脓毒症动物血浆在体外生成凝血酶的能力降低来反映。给予NSC23766可增加CLP小鼠血浆中的峰值和总TG,表明Rac-1调节脓毒症诱导的凝血酶形成。腹部脓毒症动物的循环PMPs数量显著升高。用NSC23766治疗可显著减少脓毒症小鼠中PMPs的形成。体外血小板激活导致大量微粒释放。值得注意的是,NSC23766在体外可消除激活血小板中PMPs的形成。这些发现表明,Rac-1在脓毒症中调节PMPs形成和TG,抑制Rac1活性可能是抑制腹部脓毒症中凝血功能障碍的一个有用靶点。